Unlocking lasting weight and metabolic wellness through multiple biological pathways

Sometimes the answer is hiding in plain sight. Healthy weight and metabolic balance depend on a constellation of pathways working together, not by any single ‘magic-bullet’ mechanism. That’s why the functional ingredients that truly make a lasting difference are the ones capable of influencing several pathways at once. This reality, supported by emerging research, is often lost in the marketing frenzy surrounding that latest wave of ‘GLP-1-inspired’ products. As consumers become more discerning, brands face increasing pressure to differentiate and to deliver measurable, sustainable results. Supporting satiety alone isn’t enough. Neither is nudging glucose nor inhibiting digestive enzymes in isolation. Ingredients offering a more coordinated, multi-pathway approach are far better aligned with the holistic wellness mindset now favored by consumers of all ages. That’s where Gateway Health Alliances’ patented botanical extracts, Dyglomera® and CQR-300®, stand apart. Backed by one of the largest and most consistent bodies of clinical research in the category, these ingredients work across multiple mechanisms that influence appetite, energy intake, glucose and lipid metabolism and natural GLP-1 activity. Fourteen peer-reviewed clinical studies involving nearly 2,000 participants demonstrate robust and consistent improvements in weight management and key metabolic and cardiovascular biomarkers. With small daily serving sizes – just 300mg to 400mg – and highly favorable formulation characteristics, Dyglomera and CQR-300 offer an exceptional foundation for innovative foods, beverages and supplements that support healthy weight management and metabolic wellness. Dyglomera and CQR-300 are botanical extracts with long histories in traditional diets and medicine. Dyglomera is derived from Dichrostachys glomerata , an African spice fruit rich in polyphenols. CQR-300 is a standardized extract of Cissus quadrangularis , a succulent long used in Ayurvedic traditions to support bone, joint and metabolic health. Gateway Health Alliances has spent more than two decades transforming these botanicals into precisely characterized, clinically validated extracts with standardized bioactive profiles. Using patented extraction and purification processes, Gateway isolates the key polyphenols and active constituents responsible for their metabolic effects. Gateway’s latest clinical research provides compelling new insight into how its flagship botanical extracts help regulate appetite, support metabolic balance and drive meaningful weight outcomes. In a large, randomized, double-blind, placebo-controlled study of 248 overweight and obese adults, both Dyglomera and CQR-300 demonstrated the ability to increase natural GLP-1 activity by modulating dipeptidyl peptidase-4 (DPP-4) – the enzyme responsible for rapidly degrading GLP-1. 4 By reducing DPP-4 activity, GLP-1 remains active longer, helping regulate appetite, prolong satiety and support healthy post-meal glucose handling. Rather than overriding physiology, the extracts supports normal metabolic signaling, making it well-suited for daily, long-term use. These new findings confirm an important addition to the mechanistic toolbox of Gateway ingredients, which deliver a coordinated, multi-pathway response across hormonal and metabolic systems – not just GLP-1 alone. Key outcomes from the 16-week human trial: 4 GLP-1 biology Body-weight and body-composition results Behavioral and satiety effects Metabolic markers Together, these results position Dyglomera and CQR-300 as innovative natural solutions capable of maintaining healthy GLP-1 levels through well-defined biochemical pathways. Dyglomera and CQR-300 have long been recognized for their broad weight management and metabolic-health benefits. Across 14 peer-reviewed clinical studies over nearly two decades, the extracts modulate multiple hormones and pathways that influence appetite, energy balance and glucose and lipid metabolism. Together, these data reinforces what metabolic researchers have long known: lasting weight management requires influencing more than one pathway. Gateway’s ingredients support this interlocking system. Both extracts have demonstrated excellent tolerability across multiple clinical trials with no serious adverse events. Their food-based origins, long histories of safe traditional use, and low daily dose (300mg to 400 mg) support a strong safety profile. Dedicated toxicology studies – including acute and sub-chronic toxicity, genotoxicity and standard safety pharmacology – validated their safety. The extracts show no stimulant-like effects, no cardiovascular stress and none of the gastrointestinal discomfort often associated with other weight management ingredients. 11, 12 Dyglomera and CQR-300 deliver on everything manufacturers require and consumers want, including convenience, great taste and seamless integration into foods, beverages and supplements. These formulation advantages make Gateway extracts ideal for weight-management supplements, metabolic wellness blends, active-lifestyle formulations, functional beverages and emerging ‘metabolic foods’ bridging nutrition and supplementation. In contrast to high-dose blends or costly single-mechanism actives, these ingredients enable formulators to deliver clinically substantiated products without compromising consumer experience. As the market shifts toward holistic, clinically backed metabolic wellness, brands need ingredients that differentiate, perform and stand up to regulatory scrutiny. Dyglomera and CQR-300 are uniquely positioned to help formulators meet that moment with botanicals that: Access peer-reviewed research and clinical insights here and discover how these ingredients can elevate your product portfolio. References